NCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed
Clinical Trials
3 trialsNCT00238797 2011-01-21
A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme
AstraZeneca
Phase 2 Completed
NCT00234442 2009-06-30
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
AstraZeneca
Phase 2 Terminated